BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38696576)

  • 1. CDK4/6 activity is required during G
    McKenney C; Lendner Y; Guerrero Zuniga A; Sinha N; Veresko B; Aikin TJ; Regot S
    Science; 2024 May; 384(6695):eadi2421. PubMed ID: 38696576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation.
    Yang HW; Cappell SD; Jaimovich A; Liu C; Chung M; Daigh LH; Pack LR; Fan Y; Regot S; Covert M; Meyer T
    Elife; 2020 Apr; 9():. PubMed ID: 32255427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of CDK4/6 activity in S/G2 phase leads to cell cycle reversal.
    Cornwell JA; Crncec A; Afifi MM; Tang K; Amin R; Cappell SD
    Nature; 2023 Jul; 619(7969):363-370. PubMed ID: 37407814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cdk7-Cdk4 T-loop phosphorylation cascade promotes G1 progression.
    Schachter MM; Merrick KA; Larochelle S; Hirschi A; Zhang C; Shokat KM; Rubin SM; Fisher RP
    Mol Cell; 2013 Apr; 50(2):250-60. PubMed ID: 23622515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption.
    Stewart ZA; Leach SD; Pietenpol JA
    Mol Cell Biol; 1999 Jan; 19(1):205-15. PubMed ID: 9858545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient Hysteresis in CDK4/6 Activity Underlies Passage of the Restriction Point in G1.
    Chung M; Liu C; Yang HW; Köberlin MS; Cappell SD; Meyer T
    Mol Cell; 2019 Nov; 76(4):562-573.e4. PubMed ID: 31543423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of pRb by cyclin D kinase is necessary for development of cardiac hypertrophy.
    Hinrichsen R; Hansen AH; Haunsø S; Busk PK
    Cell Prolif; 2008 Oct; 41(5):813-29. PubMed ID: 18700867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence.
    Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G
    Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the DNA damage response by therapeutic CDK4/6 inhibition.
    Dean JL; McClendon AK; Knudsen ES
    J Biol Chem; 2012 Aug; 287(34):29075-87. PubMed ID: 22733811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOG1 transcription factor promotes the onset of endoreduplication under salinity stress in Arabidopsis.
    Mahapatra K; Roy S
    Sci Rep; 2021 Jun; 11(1):11659. PubMed ID: 34079040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
    Keenan SM; Lents NH; Baldassare JJ
    J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability.
    Dozier C; Mazzolini L; Cénac C; Froment C; Burlet-Schiltz O; Besson A; Manenti S
    Oncogene; 2017 Jun; 36(26):3781-3788. PubMed ID: 28192398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor-positive Breast Cancer.
    Michaloglou C; Crafter C; Siersbaek R; Delpuech O; Curwen JO; Carnevalli LS; Staniszewska AD; Polanska UM; Cheraghchi-Bashi A; Lawson M; Chernukhin I; McEwen R; Carroll JS; Cosulich SC
    Mol Cancer Ther; 2018 May; 17(5):908-920. PubMed ID: 29483206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice thrive without Cdk4 and Cdk2.
    Barrière C; Santamaría D; Cerqueira A; Galán J; Martín A; Ortega S; Malumbres M; Dubus P; Barbacid M
    Mol Oncol; 2007 Jun; 1(1):72-83. PubMed ID: 19383288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mateyak MK; Obaya AJ; Sedivy JM
    Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical modelling of reversible transition between quiescence and proliferation.
    Pandey N; Vinod PK
    PLoS One; 2018; 13(6):e0198420. PubMed ID: 29856829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDC25A targeting by miR-483-3p decreases CCND-CDK4/6 assembly and contributes to cell cycle arrest.
    Bertero T; Gastaldi C; Bourget-Ponzio I; Mari B; Meneguzzi G; Barbry P; Ponzio G; Rezzonico R
    Cell Death Differ; 2013 Jun; 20(6):800-11. PubMed ID: 23429262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.
    Bisteau X; Paternot S; Colleoni B; Ecker K; Coulonval K; De Groote P; Declercq W; Hengst L; Roger PP
    PLoS Genet; 2013 May; 9(5):e1003546. PubMed ID: 23737759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Inactivation of Pocket Proteins and APC/C
    Shaltiel IA; Llopis A; Aprelia M; Klompmaker R; Menegakis A; Krenning L; Medema RH
    Cells; 2021 Mar; 10(3):. PubMed ID: 33806417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex.
    Lukas C; Sørensen CS; Kramer E; Santoni-Rugiu E; Lindeneg C; Peters JM; Bartek J; Lukas J
    Nature; 1999 Oct; 401(6755):815-8. PubMed ID: 10548110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.